Global Sarcopenia Therapeutic Market Growth (Status and Outlook) 2023-2029

March 2023 | 100 pages | ID: G46B395EE00DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.

LPI (LP Information)' newest research report, the “Sarcopenia Therapeutic Industry Forecast” looks at past sales and reviews total world Sarcopenia Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Sarcopenia Therapeutic sales for 2023 through 2029. With Sarcopenia Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sarcopenia Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global Sarcopenia Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sarcopenia Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sarcopenia Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sarcopenia Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sarcopenia Therapeutic.

The global Sarcopenia Therapeutic market size is projected to grow from US$ 2702.7 million in 2022 to US$ 3420.8 million in 2029; it is expected to grow at a CAGR of 3.4% from 2023 to 2029.

China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.

This report presents a comprehensive overview, market shares, and growth opportunities of Sarcopenia Therapeutic market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Protein Supplement
• Calcium Supplement
• Other

Segmentation by application

• Online Pharmacies
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• Nestl?
• Pfizer
• Amway
• By-health
• Usana
• A&Z Pharmaceutical
• GlaxoSmithKline
• Bayer
• H&H
• Blackmores
• Zhendong Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sarcopenia Therapeutic Market Size 2018-2029
  2.1.2 Sarcopenia Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Sarcopenia Therapeutic Segment by Type
  2.2.1 Protein Supplement
  2.2.2 Calcium Supplement
  2.2.3 Other
2.3 Sarcopenia Therapeutic Market Size by Type
  2.3.1 Sarcopenia Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Sarcopenia Therapeutic Segment by Application
  2.4.1 Online Pharmacies
  2.4.2 Retail Pharmacies
2.5 Sarcopenia Therapeutic Market Size by Application
  2.5.1 Sarcopenia Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)

3 SARCOPENIA THERAPEUTIC MARKET SIZE BY PLAYER

3.1 Sarcopenia Therapeutic Market Size Market Share by Players
  3.1.1 Global Sarcopenia Therapeutic Revenue by Players (2018-2023)
  3.1.2 Global Sarcopenia Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Sarcopenia Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SARCOPENIA THERAPEUTIC BY REGIONS

4.1 Sarcopenia Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Sarcopenia Therapeutic Market Size Growth (2018-2023)
4.3 APAC Sarcopenia Therapeutic Market Size Growth (2018-2023)
4.4 Europe Sarcopenia Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Sarcopenia Therapeutic Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Sarcopenia Therapeutic Market Size by Country (2018-2023)
5.2 Americas Sarcopenia Therapeutic Market Size by Type (2018-2023)
5.3 Americas Sarcopenia Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sarcopenia Therapeutic Market Size by Region (2018-2023)
6.2 APAC Sarcopenia Therapeutic Market Size by Type (2018-2023)
6.3 APAC Sarcopenia Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sarcopenia Therapeutic by Country (2018-2023)
7.2 Europe Sarcopenia Therapeutic Market Size by Type (2018-2023)
7.3 Europe Sarcopenia Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sarcopenia Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SARCOPENIA THERAPEUTIC MARKET FORECAST

10.1 Global Sarcopenia Therapeutic Forecast by Regions (2024-2029)
  10.1.1 Global Sarcopenia Therapeutic Forecast by Regions (2024-2029)
  10.1.2 Americas Sarcopenia Therapeutic Forecast
  10.1.3 APAC Sarcopenia Therapeutic Forecast
  10.1.4 Europe Sarcopenia Therapeutic Forecast
  10.1.5 Middle East & Africa Sarcopenia Therapeutic Forecast
10.2 Americas Sarcopenia Therapeutic Forecast by Country (2024-2029)
  10.2.1 United States Sarcopenia Therapeutic Market Forecast
  10.2.2 Canada Sarcopenia Therapeutic Market Forecast
  10.2.3 Mexico Sarcopenia Therapeutic Market Forecast
  10.2.4 Brazil Sarcopenia Therapeutic Market Forecast
10.3 APAC Sarcopenia Therapeutic Forecast by Region (2024-2029)
  10.3.1 China Sarcopenia Therapeutic Market Forecast
  10.3.2 Japan Sarcopenia Therapeutic Market Forecast
  10.3.3 Korea Sarcopenia Therapeutic Market Forecast
  10.3.4 Southeast Asia Sarcopenia Therapeutic Market Forecast
  10.3.5 India Sarcopenia Therapeutic Market Forecast
  10.3.6 Australia Sarcopenia Therapeutic Market Forecast
10.4 Europe Sarcopenia Therapeutic Forecast by Country (2024-2029)
  10.4.1 Germany Sarcopenia Therapeutic Market Forecast
  10.4.2 France Sarcopenia Therapeutic Market Forecast
  10.4.3 UK Sarcopenia Therapeutic Market Forecast
  10.4.4 Italy Sarcopenia Therapeutic Market Forecast
  10.4.5 Russia Sarcopenia Therapeutic Market Forecast
10.5 Middle East & Africa Sarcopenia Therapeutic Forecast by Region (2024-2029)
  10.5.1 Egypt Sarcopenia Therapeutic Market Forecast
  10.5.2 South Africa Sarcopenia Therapeutic Market Forecast
  10.5.3 Israel Sarcopenia Therapeutic Market Forecast
  10.5.4 Turkey Sarcopenia Therapeutic Market Forecast
  10.5.5 GCC Countries Sarcopenia Therapeutic Market Forecast
10.6 Global Sarcopenia Therapeutic Forecast by Type (2024-2029)
10.7 Global Sarcopenia Therapeutic Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories Sarcopenia Therapeutic Product Offered
  11.1.3 Abbott Laboratories Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 Nestl?
  11.2.1 Nestl? Company Information
  11.2.2 Nestl? Sarcopenia Therapeutic Product Offered
  11.2.3 Nestl? Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Nestl? Main Business Overview
  11.2.5 Nestl? Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Sarcopenia Therapeutic Product Offered
  11.3.3 Pfizer Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Amway
  11.4.1 Amway Company Information
  11.4.2 Amway Sarcopenia Therapeutic Product Offered
  11.4.3 Amway Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Amway Main Business Overview
  11.4.5 Amway Latest Developments
11.5 By-health
  11.5.1 By-health Company Information
  11.5.2 By-health Sarcopenia Therapeutic Product Offered
  11.5.3 By-health Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 By-health Main Business Overview
  11.5.5 By-health Latest Developments
11.6 Usana
  11.6.1 Usana Company Information
  11.6.2 Usana Sarcopenia Therapeutic Product Offered
  11.6.3 Usana Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Usana Main Business Overview
  11.6.5 Usana Latest Developments
11.7 A&Z Pharmaceutical
  11.7.1 A&Z Pharmaceutical Company Information
  11.7.2 A&Z Pharmaceutical Sarcopenia Therapeutic Product Offered
  11.7.3 A&Z Pharmaceutical Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 A&Z Pharmaceutical Main Business Overview
  11.7.5 A&Z Pharmaceutical Latest Developments
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Information
  11.8.2 GlaxoSmithKline Sarcopenia Therapeutic Product Offered
  11.8.3 GlaxoSmithKline Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 GlaxoSmithKline Main Business Overview
  11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer Sarcopenia Therapeutic Product Offered
  11.9.3 Bayer Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 H&H
  11.10.1 H&H Company Information
  11.10.2 H&H Sarcopenia Therapeutic Product Offered
  11.10.3 H&H Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 H&H Main Business Overview
  11.10.5 H&H Latest Developments
11.11 Blackmores
  11.11.1 Blackmores Company Information
  11.11.2 Blackmores Sarcopenia Therapeutic Product Offered
  11.11.3 Blackmores Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Blackmores Main Business Overview
  11.11.5 Blackmores Latest Developments
11.12 Zhendong Group
  11.12.1 Zhendong Group Company Information
  11.12.2 Zhendong Group Sarcopenia Therapeutic Product Offered
  11.12.3 Zhendong Group Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Zhendong Group Main Business Overview
  11.12.5 Zhendong Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Sarcopenia Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Protein Supplement
Table 3. Major Players of Calcium Supplement
Table 4. Major Players of Other
Table 5. Sarcopenia Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Sarcopenia Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Table 8. Sarcopenia Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Sarcopenia Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Table 11. Global Sarcopenia Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Sarcopenia Therapeutic Revenue Market Share by Player (2018-2023)
Table 13. Sarcopenia Therapeutic Key Players Head office and Products Offered
Table 14. Sarcopenia Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sarcopenia Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Sarcopenia Therapeutic Market Size Market Share by Regions (2018-2023)
Table 19. Global Sarcopenia Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Sarcopenia Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Sarcopenia Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Sarcopenia Therapeutic Market Size Market Share by Country (2018-2023)
Table 23. Americas Sarcopenia Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Table 25. Americas Sarcopenia Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Table 27. APAC Sarcopenia Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Sarcopenia Therapeutic Market Size Market Share by Region (2018-2023)
Table 29. APAC Sarcopenia Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Table 31. APAC Sarcopenia Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Table 33. Europe Sarcopenia Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Sarcopenia Therapeutic Market Size Market Share by Country (2018-2023)
Table 35. Europe Sarcopenia Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Table 37. Europe Sarcopenia Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Sarcopenia Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Sarcopenia Therapeutic
Table 46. Key Market Challenges & Risks of Sarcopenia Therapeutic
Table 47. Key Industry Trends of Sarcopenia Therapeutic
Table 48. Global Sarcopenia Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Sarcopenia Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Sarcopenia Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Sarcopenia Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Abbott Laboratories Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 53. Abbott Laboratories Sarcopenia Therapeutic Product Offered
Table 54. Abbott Laboratories Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. Nestl? Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 58. Nestl? Sarcopenia Therapeutic Product Offered
Table 59. Nestl? Main Business
Table 60. Nestl? Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Nestl? Latest Developments
Table 62. Pfizer Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 63. Pfizer Sarcopenia Therapeutic Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Pfizer Latest Developments
Table 67. Amway Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 68. Amway Sarcopenia Therapeutic Product Offered
Table 69. Amway Main Business
Table 70. Amway Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Amway Latest Developments
Table 72. By-health Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 73. By-health Sarcopenia Therapeutic Product Offered
Table 74. By-health Main Business
Table 75. By-health Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. By-health Latest Developments
Table 77. Usana Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 78. Usana Sarcopenia Therapeutic Product Offered
Table 79. Usana Main Business
Table 80. Usana Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Usana Latest Developments
Table 82. A&Z Pharmaceutical Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 83. A&Z Pharmaceutical Sarcopenia Therapeutic Product Offered
Table 84. A&Z Pharmaceutical Main Business
Table 85. A&Z Pharmaceutical Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. A&Z Pharmaceutical Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 88. GlaxoSmithKline Sarcopenia Therapeutic Product Offered
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. GlaxoSmithKline Latest Developments
Table 92. Bayer Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 93. Bayer Sarcopenia Therapeutic Product Offered
Table 94. Bayer Main Business
Table 95. Bayer Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Bayer Latest Developments
Table 97. H&H Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 98. H&H Sarcopenia Therapeutic Product Offered
Table 99. H&H Main Business
Table 100. H&H Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. H&H Latest Developments
Table 102. Blackmores Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 103. Blackmores Sarcopenia Therapeutic Product Offered
Table 104. Blackmores Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Blackmores Main Business
Table 106. Blackmores Latest Developments
Table 107. Zhendong Group Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 108. Zhendong Group Sarcopenia Therapeutic Product Offered
Table 109. Zhendong Group Main Business
Table 110. Zhendong Group Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Zhendong Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Sarcopenia Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sarcopenia Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Sarcopenia Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Sarcopenia Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Sarcopenia Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Sarcopenia Therapeutic Market Size Market Share by Type in 2022
Figure 10. Sarcopenia Therapeutic in Online Pharmacies
Figure 11. Global Sarcopenia Therapeutic Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 12. Sarcopenia Therapeutic in Retail Pharmacies
Figure 13. Global Sarcopenia Therapeutic Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Global Sarcopenia Therapeutic Market Size Market Share by Application in 2022
Figure 15. Global Sarcopenia Therapeutic Revenue Market Share by Player in 2022
Figure 16. Global Sarcopenia Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Sarcopenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure 18. APAC Sarcopenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure 19. Europe Sarcopenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Sarcopenia Therapeutic Market Size 2018-2023 ($ Millions)
Figure 21. Americas Sarcopenia Therapeutic Value Market Share by Country in 2022
Figure 22. United States Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Sarcopenia Therapeutic Market Size Market Share by Region in 2022
Figure 27. APAC Sarcopenia Therapeutic Market Size Market Share by Type in 2022
Figure 28. APAC Sarcopenia Therapeutic Market Size Market Share by Application in 2022
Figure 29. China Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Sarcopenia Therapeutic Market Size Market Share by Country in 2022
Figure 36. Europe Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Figure 37. Europe Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Figure 38. Germany Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Sarcopenia Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 52. APAC Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 53. Europe Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 55. United States Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. Canada Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. China Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Japan Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. Korea Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. India Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Australia Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. Germany Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. France Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. UK Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. Italy Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. Russia Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. Spain Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Israel Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Sarcopenia Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. Global Sarcopenia Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Sarcopenia Therapeutic Market Size Market Share Forecast by Application (2024-2029)